A pilot study of streptokinase therapy in acute myocardial infarction: observations on complications and relation to trial design.
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000139:chemically induced; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D002319:Cardiovascular System / Q000187:drug effects*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004342:Drug Hypersensitivity; D005260:Female; D005334:Fever / Q000139:chemically induced*; D006333:Heart Failure / Q000139:chemically induced; D006339:Heart Rate / Q000187:drug effects*; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000139:chemically induced / Q000188:drug therapy*; D010689:Phlebitis / Q000139:chemically induced; D010865:Pilot Projects; D011655:Pulmonary Embolism / Q000139:chemically induced; D012769:Shock / Q000139:chemically induced; D013299:Streptodornase and Streptokinase / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D013610:Tachycardia / Q000139:chemically induced
D013299:Streptodornase and Streptokinase